Literature DB >> 8020565

Discrete early pro-B and pre-B stages in normal human bone marrow as defined by surface pseudo-light chain expression.

V Guelpa-Fonlupt1, C Tonnelle, D Blaise, M Fougereau, F Fumoux.   

Abstract

Vpre-B and lambda-like genes are selectively expressed in B cell precursors and encode polypeptide chains associated in a mu-pseudo light chain (mu-psi L) complex which is thought to regulate some early steps of B cell differentiation. We have generated anti-Vpre-B monoclonal antibodies which allowed us to identify different steps of differentiation from the pro-B to the immature B cells by following surface expression of Vpre-B, mu and light chains in normal adult human bone marrow. Already present at the surface of a small fraction of B cell progenitors (CD34+/CD19+) the Vpre-B molecule was consistently found coexpressed with CD19 and was also found with the sequentially occurring CD10, CD20, CD21, CD22 and CD5 markers. Three discrete cell types were identified: (i) a subpopulation expressing Vpre-B without mu and which represented an early stage of differentiation, (ii) a minor subpopulation co-expressing Vpre-B and mu without the conventional light chains and (iii) a major subpopulation co-expressing Vpre-B, mu and kappa or lambda chains, considered an intermediate pre-B/B stage. The presence of the psi L chain in various cell subpopulations, in possible association with discrete molecules and/or different contexts, suggests its involvement at several steps of early B cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020565     DOI: 10.1002/eji.1830240140

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Mutations in Igalpha (CD79a) result in a complete block in B-cell development.

Authors:  Y Minegishi; E Coustan-Smith; L Rapalus; F Ersoy; D Campana; M E Conley
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

2.  A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.

Authors:  E Meffre; F LeDeist; G de Saint-Basile; A Deville; M Fougereau; A Fischer; C Schiff
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

3.  Fate of surrogate light chains in B lineage cells.

Authors:  K Lassoued; H Illges; K Benlagha; M D Cooper
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

4.  A novel anti-Vpre-B antibody identifies immunoglobulin-surrogate receptors on the surface of human pro-B cells.

Authors:  E Sanz; A de la Hera
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

5.  Ordering of human bone marrow B lymphocyte precursors by single-cell polymerase chain reaction analyses of the rearrangement status of the immunoglobulin H and L chain gene loci.

Authors:  P Ghia; E ten Boekel; E Sanz; A de la Hera; A Rolink; F Melchers
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

6.  CD25 + B-1a Cells Express Aicda.

Authors:  Hiroaki Kaku; Nichol E Holodick; Joseph R Tumang; Thomas L Rothstein
Journal:  Front Immunol       Date:  2017-06-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.